FilippiMBrückWChardD, et al. Association between pathological and MRI findings in multiple sclerosis. Lancet Neurol2019; 18(2): 198–210.
2.
KapposLWolinskyJSGiovannoniG, et al. Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials. JAMA Neurol2020; 77(9): 1132–1140.
3.
YoungIRHallASPallisCA, et al. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet1981; 2(8255): 1063–1066.
4.
PrineasJWKwonEEChoES, et al. Immunopathology of secondary-progressive multiple sclerosis. Ann Neurol2001; 50(5): 646–657.
5.
AbsintaMDal-BiancoA. Slowly expanding lesions are a marker of progressive MS – Yes. Mult Scler2021; 27(11): 1679–1681.
6.
ArnoldDLBelachewSGafsonAR, et al. Slowly expanding lesions are a marker of progressive MS – No. Mult Scler2021; 27(11): 1681–1683.
7.
SchoonheimMMPinterDProuskasSE, et al. Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy. Mult Scler. Epub ahead of print 19 April 2021. DOI: 10.1177/13524585211008743.
8.
PinterDKhalilMPirpamerL, et al. Long-term course and morphological MRI correlates of cognitive function in multiple sclerosis. Mult Scler2021; 27(6): 954–963.
9.
Sastre-GarrigaJParetoDBattagliniM, et al. MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice. Nat Rev Neurol2020; 16(3): 171–182.
10.
PinterDBeckmannCFFazekasF, et al. Morphological MRI phenotypes of multiple sclerosis differ in resting-state brain function. Sci Rep2019; 9(1): 16221.
11.
GranzieraCWuerfelJBarkhofF, et al.; MAGNIMS Study Group. Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis. Brain2021; 144(5): 1296–1311.
12.
WattjesMPCiccarelliOReichDS, et al.; Magnetic Resonance Imaging in Multiple Sclerosis Study Group; Consortium of Multiple Sclerosis Centres; North American Imaging in Multiple Sclerosis Cooperative MRI Guidelines Working Group. 2021 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI in patients with multiple sclerosis. Lancet Neurol2021; 20: 653–670.
